Anthony Onoja
Biomarkers of kidney failure and all-cause mortality in chronic kidney disease
Onoja, Anthony; McDonnell, Thomas; Annessi, Isabelle; Banks, Rosamonde E; Bergin, Marianne; Cockwell, Paul; Dusaulcy, Rodolphe; Fraser, Simon DS; Johnson, Tim; Kalra, Philip A; Lemaître, Barbara; Saleem, Moin; Skroblin, Phillipp; Soderberg, Magnus; Taal, Maarten W; Unwin, Robert J; Vuilleumier, Nicolas; Wheeler, David C; Geifman, Nophar
Authors
Thomas McDonnell
Isabelle Annessi
Rosamonde E Banks
Marianne Bergin
Paul Cockwell
Rodolphe Dusaulcy
Simon DS Fraser
Tim Johnson
Philip A Kalra
Barbara Lemaître
Moin Saleem
Phillipp Skroblin
Magnus Soderberg
Professor MAARTEN TAAL M.TAAL@NOTTINGHAM.AC.UK
PROFESSOR OF MEDICINE
Robert J Unwin
Nicolas Vuilleumier
David C Wheeler
Nophar Geifman
Abstract
Background:
Chronic kidney disease (CKD) carries a variable risk for multiple adverse outcomes, highlighting the need for a personalised approach. This study evaluated several novel biomarkers linked to key disease mechanisms to predict the risk of kidney failure (first event of eGFR <15 ml/min/1.73m2 or kidney replacement therapy), all-cause mortality, and a composite of both.
Methods:
We included 2,884 adults with non-dialysis CKD from 16 nephrology centres across the UK. Twenty-one biomarkers associated with kidney damage, fibrosis, inflammation, and cardiovascular disease were analysed in urine, plasma, or serum. Cox proportional hazards models were used to assess biomarker associations and develop risk prediction models.
Results:
Participants had mean age 63 (15) years, 58% were male and 87% White. Median eGFR 35 (25, 47) ml/min/1.73m2, and median urinary albumin-to-creatinine ratio (UACR) 197 (32, 895) mg/g. During median 48 (33, 55) months follow-up, 680 kidney failure events and 414 all-cause mortality events occurred. For kidney failure, a model combining three biomarkers (sTNFR1, sCD40, UCOL1A1) showed good discrimination (c-index 0.86, 95% CI: 0.83–0.89) but was outperformed by a model using established risk factors (age, sex, ethnicity, eGFR, UACR; c-index 0.90, 95% CI: 0.88–0.92). For all-cause mortality, a model using three biomarkers (hs-cTnT, NT-proBNP, suPAR) demonstrated equivalent discrimination (c-index 0.80, 95% CI: 0.75–0.84) to an established risk factor model (c-index 0.80, 95% CI: 0.76–0.84).For the composite outcome, the biomarker model discrimination (C-index 0.78, 95% CI: 0.76, 0.81) was numerically higher than for established risk factors (C-index 0.77, 95% CI: 0.74, 0.80), and the addition of biomarkers to the established risk factors led to a small but statistically significant improvement in discrimination (C-index 0.80, 95% CI: 0.77, 0.82; p value < 0.01)
Conclusions:
Risk prediction models incorporating novel biomarkers showed comparable discrimination to established risk factors for kidney failure and all-cause mortality.
Citation
Onoja, A., McDonnell, T., Annessi, I., Banks, R. E., Bergin, M., Cockwell, P., Dusaulcy, R., Fraser, S. D., Johnson, T., Kalra, P. A., Lemaître, B., Saleem, M., Skroblin, P., Soderberg, M., Taal, M. W., Unwin, R. J., Vuilleumier, N., Wheeler, D. C., & Geifman, N. (2025). Biomarkers of kidney failure and all-cause mortality in chronic kidney disease. Journal of the American Society of Nephrology, https://doi.org/10.1681/ASN.0000000767
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 16, 2025 |
Online Publication Date | Jun 20, 2025 |
Publication Date | Jun 20, 2025 |
Deposit Date | Jun 18, 2025 |
Publicly Available Date | Jun 21, 2026 |
Journal | Journal of the American Society of Nephrology |
Print ISSN | 1046-6673 |
Electronic ISSN | 1533-3450 |
Publisher | American Society of Nephrology |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1681/ASN.0000000767 |
Keywords | Chronic kidney disease, biomarkers, kidney failure, Personalised medicine, CKD progression |
Public URL | https://nottingham-repository.worktribe.com/output/50443341 |
Publisher URL | https://journals.lww.com/jasn/abstract/9900/biomarkers_of_kidney_failure_and_all_cause.683.aspx |
Additional Information | This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of the American Society of Nephrology. The published version of record Onoja, A., McDonnell, T., Annessi, I., Banks, R. E., Bergin, M., Cockwell, P., Dusaulcy, R., Fraser, S. D., Johnson, T., Kalra, P. A., Lemaître, B., Saleem, M., Skroblin, P., Soderberg, M., Taal, M. W., Unwin, R. J., Vuilleumier, N., Wheeler, D. C., & Geifman, N. (2025). Biomarkers of kidney failure and all-cause mortality in chronic kidney disease. Journal of the American Society of Nephrology, is available online at: https://doi.org/10.1681/ASN.0000000767. |
Files
This file is under embargo until Jun 21, 2026 due to copyright restrictions.
You might also like
Optimizing kidney and cardiovascular protection in an era of multiple effective treatments
(2024)
Journal Article
A note on performance metrics for the Kidney Failure Risk Equation
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search